Clinical trials
Dyspnea trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Unknown status | 14 |
| Recruiting | 5 |
| Withdrawn | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| McGill University | 9 |
| University of British Columbia | 9 |
| Queen's University | 8 |
| University of Alberta | 6 |
| Dr. Denis O'Donnell | 4 |
| Laval University | 4 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Novartis Pharmaceuticals | 2 |
| Unity Health Toronto | 2 |
| University Health Network, Toronto | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyspnea | 74 |
| Pulmonary Disease, Chronic Obstructive | 32 |
| Heart Failure | 9 |
| Lung Diseases | 7 |
| Cystic Fibrosis | 6 |
| Lung Diseases, Interstitial | 6 |
| COVID-19 | 3 |
| Chest Pain | 2 |
| Disease | 2 |
| Fever | 2 |
Trials
Showing 26 to 50 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.